news
Scripps scientists make leukaemia cells kill each other
20 October 2015 | By Victoria White
The surprise finding could lead to a powerful new therapy for leukaemia and possibly other cancers...
List view / Grid view
Breast cancer
news
Breast cancer vaccine OQR200 completes proof-of-concept study
15 October 2015 | By Victoria White
In the study, the vaccine elicited the expression of very high levels of polyclonal antibodies targeting multiple epitopes on Her2/neu...
news
Tamoxifen beats MRSA superbug in mice models
13 October 2015 | By Victoria White
Researchers have found that tamoxifen gives white blood cells a boost, better enabling them to respond to and kill bacteria in laboratory experiments...
news
Cancer Research UK launches the Grand Challenge to help beat cancer
12 October 2015 | By Victoria White
International scientists across all disciplines are invited to come up with solutions to seven challenges which cover some of the most important unanswered questions in cancer research...
news
3SBio enters licensing deal for antibody-drug conjugate ALT-P7
12 October 2015 | By Victoria White
Preclinical proof-of-concept has demonstrated superiority of ALT-P7 over current drugs in murine models of HER2-positive breast cancer...
news
Nav1.5 identified as potential therapeutic target for breast cancer
9 October 2015 | By Victoria White
When using the shRNA in breast cancer cells, Nav1.5 levels were 'knocked down', resulting in reduced tumour growth rates and metastasis...
news
Two-hit approach shows promise in breast cancer study
8 October 2015 | By Victoria White
Researchers have eradicated a specific type of breast cancer tumour in mice by disabling a cancer-causing pathway and administering an immune-molecule based mop-up therapy...
news
XOMA licenses anti-TGFb antibody programme to Novartis
2 October 2015 | By Victoria White
Elevated levels of TGFb may drive the progression of advanced metastatic cancer. As such, it has become an attractive target for cancer drug development...
news
BMS and Moffitt form immuno-oncology partnership
25 September 2015 | By Victoria White
Bristol-Myers Squibb and Moffitt will conduct a range of early phase clinical studies, including clinical investigations by young investigators to strengthen their development as clinical research scientists...
news
Researchers develop a new computational method to study cancer drug effects
11 September 2015 | By Victoria White
Researchers have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry experiments...
news
SAS1B discovery could fundamentally alter cancer treatment
10 September 2015 | By Victoria White
The SAS1B protein appears only on egg cells and cancer cells, and could serve as a target for tiny tracking probes created using monoclonal antibodies...
news
Aspirin could boost cancer immunotherapy
4 September 2015 | By Victoria White
Researchers have shown that combining immunotherapy with aspirin or other COX inhibitors substantially slowed bowel and melanoma skin cancer growth in mice...
news
Oncodrone to progress prostate cancer drug with €2.5m grant
25 August 2015 | By Victoria White
Oncodrone, the anti-cancer company based in Nijmegen, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155...
news
Two Stat3 inhibitors show potential in fighting brain and breast cancers
16 July 2015 | By Victoria White
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumours by inhibiting the Stat3 protein...
news
Cell mesh discovery advances understanding of cancer development
13 July 2015 | By Victoria White
University of Warwick researchers have discovered a cell structure, called 'the mesh', which could help scientists understand why some cancers develop...
